SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-008932
Filing Date
2022-03-07
Accepted
2022-03-07 16:15:41
Documents
14
Period of Report
2022-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-8k_20220307.htm   iXBRL 8-K 35405
2 EX-99.1 drrx-ex991_6.htm EX-99.1 368617
  Complete submission text file 0001564590-22-008932.txt   583692

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA drrx-20220307.xsd EX-101.SCH 6411
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drrx-20220307_def.xml EX-101.DEF 14028
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20220307_lab.xml EX-101.LAB 23853
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20220307_pre.xml EX-101.PRE 14737
8 EXTRACTED XBRL INSTANCE DOCUMENT drrx-8k_20220307_htm.xml XML 5386
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 22718177
SIC: 2834 Pharmaceutical Preparations